Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program

Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program

CCR2 is the cognate receptor to the chemokine CCL2. CCR2–CCL2 signaling mediates cancer progression and metastasis dissemination. However, the role of CCR2–CCL2 signaling in pathogenesis of B-cell malignancies is not clear. Previously, we showed that CCR2B was upregulated in ex v...

Full description

Bibliographic Details
Main Authors: Svetlana Kozireva, Zhanna Rudevica, Mikhail Baryshev, Ainars Leonciks, Elena Kashuba, Irina Kholodnyuk
Format: Article
Language:English
Published: MDPI AG 2018-05-01
Series:Viruses
Subjects:
CCR2
EBV
latency III
Burkitt lymphoma cell lines
B-cell lymphoma
Online Access:http://www.mdpi.com/1999-4915/10/5/239

Similar Items

Similar Items